Literature DB >> 22322207

Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.

Tsuyoshi Kasama1, Hidekazu Furuya, Ryo Yanai, Kumiko Ohtsuka, Ryo Takahashi, Nobuyuki Yajima, Yusuke Miwa, Kazuo Kobayashi.   

Abstract

To investigate the characteristics of patients with adult-onset Still's disease (AOSD), serum cytokines and chemokines were measured to examine their associations with systemic manifestations of AOSD, especially hemophagocytic syndrome (HPS). Nineteen patients diagnosed with AOSD were enrolled. Serial serum samples were obtained from patients with AOSD in both active and inactive stages and controls. The concentrations of cytokines and chemokines, including IL-18, soluble IL-2 receptor (sIL-2R), CX3CL1, CXCL8, CXCL10, CCL2, and CCL3, were determined using enzyme-linked immunosorbent assay. Multivariate analysis was used to evaluate the correlations among serum chemokine levels, disease activity, and the clinical features of AOSD. Significantly higher serum levels of all cytokines and chemokines were observed in patients with active, untreated AOSD than in controls. The level of CX3CL1, but not other chemokines, was elevated in AOSD patients and was positively correlated with clinical activity and the levels of CRP, ferritin, IL-18, and sIL-2R. Among the 19 patients with AOSD, four patients also had HPS. Serum CX3CL1 and ferritin were significantly higher in AOSD patients with HPS than in those without HPS. The serum CX3CL1 level may be used as a clinical marker to assess the disease activity of AOSD, and high serum CX3CL1 and ferritin in patients with AOSD reflected the presence of HPS. The association between the chemokine profile and distinct clinical manifestations or various patterns of disease progression indicates that the pathogenesis of AOSD is heterogeneous.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322207     DOI: 10.1007/s10067-012-1952-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  40 in total

Review 1.  A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature.

Authors:  Katja Perdan-Pirkmajer; Sonja Praprotnik; Matija Tomšič
Journal:  Clin Rheumatol       Date:  2010-08-24       Impact factor: 2.980

2.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

3.  Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients.

Authors:  Arnaud Hot; Myew-Ling Toh; Brigitte Coppéré; Laurent Perard; Marie Hélène Girard Madoux; Christelle Mausservey; Hélène Desmurs-Clavel; Martine Ffrench; Jacques Ninet
Journal:  Medicine (Baltimore)       Date:  2010-01       Impact factor: 1.889

4.  Adult Still's disease: manifestations, disease course, and outcome in 62 patients.

Authors:  J Pouchot; J S Sampalis; F Beaudet; S Carette; F Décary; M Salusinsky-Sternbach; R O Hill; A Gutkowski; M Harth; D Myhal
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

5.  Interleukin 6: a possible marker of disease activity in adult onset Still's disease.

Authors:  M A Scheinberg; E Chapira; M L Fernandes; O Hubscher
Journal:  Clin Exp Rheumatol       Date:  1996 Nov-Dec       Impact factor: 4.473

6.  Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.

Authors:  Petronela Ancuta; Ashlee Moses; Dana Gabuzda
Journal:  Immunobiology       Date:  2004       Impact factor: 3.144

Review 7.  Pathogenesis of hemophagocytic syndrome (HPS).

Authors:  Claire Larroche; Luc Mouthon
Journal:  Autoimmun Rev       Date:  2004-02       Impact factor: 9.754

8.  Serum cytokine profiles in patients with adult onset Still's disease.

Authors:  Jeong-Hee Choi; Chang-Hee Suh; Young-Mok Lee; Yu-Jin Suh; Soo-Keol Lee; Sun-Sin Kim; Dong-Ho Nahm; Hae-Sim Park
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

9.  Elevated serum levels of soluble CX3CL1 in patients with microscopic polyangiitis.

Authors:  M Matsunawa; T Odai; K Wakabayashi; T Isozaki; N Yajima; Y Miwa; K Nohtomi; H Takeuchi; T Kasama
Journal:  Clin Exp Rheumatol       Date:  2009 Jan-Feb       Impact factor: 4.473

10.  Adult-onset Still's disease. Clinical course and outcome.

Authors:  J J Cush; T A Medsger; W C Christy; D C Herbert; L A Cooperstein
Journal:  Arthritis Rheum       Date:  1987-02
View more
  11 in total

Review 1.  Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Authors:  Paolo Sfriso; Sara Bindoli; Paola Galozzi
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 2.  Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.

Authors:  Ken Goda; Tsuneaki Kenzaka; Masahiko Hoshijima; Akihiro Yachie; Hozuka Akita
Journal:  Rheumatol Int       Date:  2019-09-20       Impact factor: 2.631

3.  Rps27a might act as a controller of microglia activation in triggering neurodegenerative diseases.

Authors:  Nasibeh Khayer; Mehdi Mirzaie; Sayed-Amir Marashi; Maryam Jalessi
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

Review 4.  Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.

Authors:  Meng-Yan Wang; Jin-Chao Jia; Cheng-De Yang; Qiong-Yi Hu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

Review 5.  An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease.

Authors:  Ji-Won Kim; Mi-Hyun Ahn; Ju-Yang Jung; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

6.  Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

Authors:  Clio P Mavragani; Evangelos G Spyridakis; Michael Koutsilieris
Journal:  Int J Inflam       Date:  2012-06-26

7.  Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.

Authors:  Jae Ho Han; Chang-Hee Suh; Ju-Yang Jung; Jin-Young Nam; Jee Eun Kwon; Hyunee Yim; Hyoun-Ah Kim
Journal:  Arthritis Res Ther       Date:  2015-09-19       Impact factor: 5.156

8.  Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease.

Authors:  Jae Ho Han; Chang-Hee Suh; Ju-Yang Jung; Mi-Hyun Ahn; Mi Hwa Han; Ji Eun Kwon; Hyunee Yim; Hyoun-Ah Kim
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

Review 9.  Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms.

Authors:  Beatrice Maranini; Giovanni Ciancio; Marcello Govoni
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

10.  Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.

Authors:  Toshihiko Shiga; Yuji Nozaki; Daisuke Tomita; Kazuya Kishimoto; Yasuaki Hirooka; Koji Kinoshita; Masanori Funauchi; Itaru Matsumura
Journal:  Front Immunol       Date:  2021-10-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.